T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Ironwood Pharmaceuticals
IRWD
$674M
| $53.4M | 0.01% |
6,124,396
-72,106
| -1% | -$673K |
|
|
SONC
752
DELISTED
Sonic Corp
SONC
| $53.2M | 0.01% |
2,318,047
+11,650
| +0.5% | +$322K |
|
753
Lazard
LAZ
$4.43B
| $53M | 0.01% |
1,224,250
-2,795,370
| -70% | -$144M |
|
754
HDFC Bank
HDB
$119B
| $52.8M | 0.01% |
3,456,708
-258,068
| -7% | -$3.89M |
|
|
WPG
755
DELISTED
Washington Prime Group Inc.
WPG
| $52.8M | 0.01% |
502,901
+136,782
| +37% | +$15.9M |
|
|
TLMR
756
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $52.6M | 0.01% |
3,159,130
-9,040
| -0.3% | -$150K |
|
|
ONCE
757
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $52.5M | 0.01% |
1,257,408
+126,112
| +11% | +$6.58M |
|
|
EBSB
758
DELISTED
Meridian Bancorp, Inc.
EBSB
| $52.2M | 0.01% |
3,815,720
+535,990
| +16% | +$7M |
|
759
CSX Corp
CSX
$92.9B
| $52.2M | 0.01% |
5,816,106
-14,370
| -0.2% | -$141K |
|
760
Jazz Pharmaceuticals
JAZZ
$16B
| $51.6M | 0.01% |
388,237
-5,563
| -1% | -$958K |
|
|
VVC
761
DELISTED
Vectren Corporation
VVC
| $51.6M | 0.01% |
1,227,299
+423,070
| +53% | +$17.2M |
|
762
Autoliv
ALV
$8.89B
| $51.5M | 0.01% |
660,617
+73,704
| +13% | +$5.57M |
|
763
eBay
EBAY
$46.5B
| $51.5M | 0.01% |
2,106,597
-9,687,503
| -82% | -$261M |
|
764
UFP Industries
UFPI
$5.03B
| $51.3M | 0.01% |
2,670,090
-367,620
| -12% | -$7.32M |
|
|
HME
765
DELISTED
HOME PROPERTIES, INC
HME
| $51.2M | 0.01% |
684,320
-170,420
| -20% | -$12.6M |
|
766
PPG Industries
PPG
$25.5B
| $51M | 0.01% |
581,255
-894,199
| -61% | -$91M |
|
767
Moody's
MCO
$84.6B
| $50.9M | 0.01% |
518,016
+15,995
| +3% | +$1.7M |
|
768
QuidelOrtho
QDEL
$1.03B
| $50.4M | 0.01% |
2,671,540
+36,820
| +1% | +$788K |
|
769
Norfolk Southern
NSC
$75.9B
| $50.2M | 0.01% |
656,607
-28,017
| -4% | -$2.28M |
|
770
Moog Inc Class A
MOG.A
$13.5B
| $50.1M | 0.01% |
926,007
+4,670
| +0.5% | +$301K |
|
771
Trane Technologies
TT
$105B
| $49.9M | 0.01% |
982,606
-1,367,168
| -58% | -$81.7M |
|
|
UBA
772
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $49.9M | 0.01% |
2,660,430
+92,290
| +4% | +$1.73M |
|
773
Aflac
AFL
$60.7B
| $49.8M | 0.01% |
1,714,826
-7,780
| -0.5% | -$235K |
|
774
WIX.com
WIX
$3.35B
| $49.4M | 0.01% |
2,837,960
-45,375
| -2% | -$1.01M |
|
775
Viavi Solutions
VIAV
$10.6B
| $49.2M | 0.01% |
9,160,336
-31,072,686
| -77% | -$182M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.